• UCLA Health
  • myUCLAhealth
  • School of Medicine
Office of Compliance Services

Office of Compliance Services

Office of Compliance Services
  • About Our Program
    • Message from the Vice Chancellor
    • Code of Conduct & Statement of Ethics
    • Organizational Structure
    • Contact Us
    • Staff Spotlight
    • Program Description
    • Hotline Information
    • Conflict of Interest/Vendor Relations
    • Other Informative Sites
  • Compliance Services
    • Clinical Research Billing
    • Hospital Compliance
    • Professional Compliance
    • Frequently Asked Questions
    • EMTALA Compliance Program
  • Information Security & Privacy
    • Device Security
    • Additional Resources
    • HIPAA Training
    • Forms
    • Guidance and Policies
    • Frequently Asked Questions
  • Education & Training
    • Clinical Research Compliance Training
    • New and Current Faculty Training
    • EMTALA Training
    • HIPAA Training
    • Ethics Briefing/Conflict of Interest Training
    • Clinical Laboratory and Pathology Compliance Training
    • Advisory Notices
    • Webinars
  • Policies & Procedures
    • Clinical Laboratory and Pathology Compliance
    • Ronald Reagan UCLA Medical Center (Westwood)
    • Resnick Neuropsychiatric Hospital at UCLA
    • UCLA Santa Monica Medical Center
  • Compliance Tips
    • Frequently Asked Questions
    • Information Security Tips
    • Privacy Tips
    • Hospital, Physician, and Clinical Research Tips
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

Office of Compliance Services

Frequently Asked Questions

  1. Home
  2. Frequently Asked Questions

Frequently Asked Questions

Share this

What is a “Qualified Clinical Trial”?

A Qualified Clinical Trial is a clinical trial that is “Qualified” for coverage of routine costs under the Medicare Clinical Trial Policy by meeting both of the following criteria:   
The “3 requirements”:
    1. The study evaluates an item/service within a Medicare benefit category that is not statutorily excluded, and  
    2. The study has therapeutic intent, and
    3. The study enrolls patients with diagnosed disease (but may enroll healthy control group.)
 AND: “Deemed” to meet the additional required 7 Desirable Characteristics because it falls into one of the following:
4. Funded by NIH, CDC, AHRQ, CMS, DOD, and VA
5. Supported by centers or cooperative groups funded by NIH, CDC, AHRQ, CMS, DOD,VA
6. Conducted under an investigational new drug application (IND) reviewed by the FDA
7. Exempt from having an IND under 21 CFR 312.2(b)(1)
Self-certification by the Principal Investigator was initially contemplated but never implemented by CMS and may not be used to determine whether a study qualifies for coverage.
<ahref="http: www.cms.gov="" medicare-coverage-database="" details="" ncd-details.aspx?ncdid="1&ncdver=2&fromdb=true"">http://www.cms.gov/medicare-coverage-database/details/ncd-details.aspx?NCDId=1&ncdver=2&fromdb=true


Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Compliance Hotline
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth